- Home
- FRME vs LGND Comparison
FRME vs LGND Comparison
Compare FRME & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRME
- LGND
- Stock Information
- Founded
- FRME 1893
- LGND 1987
- Country
- FRME United States
- LGND United States
- Employees
- FRME N/A
- LGND N/A
- Industry
- FRME Major Banks
- LGND Biotechnology: Pharmaceutical Preparations
- Sector
- FRME Finance
- LGND Health Care
- Exchange
- FRME Nasdaq
- LGND Nasdaq
- Market Cap
- FRME 2.1B
- LGND 2.0B
- IPO Year
- FRME N/A
- LGND 1992
- Fundamental
- Price
- FRME $35.93
- LGND $114.07
- Analyst Decision
- FRME Buy
- LGND Strong Buy
- Analyst Count
- FRME 4
- LGND 8
- Target Price
- FRME $45.50
- LGND $144.71
- AVG Volume (30 Days)
- FRME 244.6K
- LGND 116.0K
- Earning Date
- FRME 07-24-2025
- LGND 08-05-2025
- Dividend Yield
- FRME 4.02%
- LGND N/A
- EPS Growth
- FRME 2.61
- LGND N/A
- EPS
- FRME 3.55
- LGND N/A
- Revenue
- FRME $615,411,000.00
- LGND $181,488,000.00
- Revenue This Year
- FRME $15.14
- LGND $18.41
- Revenue Next Year
- FRME $5.03
- LGND $18.87
- P/E Ratio
- FRME $10.10
- LGND N/A
- Revenue Growth
- FRME N/A
- LGND 53.40
- 52 Week Low
- FRME $31.16
- LGND $77.53
- 52 Week High
- FRME $46.13
- LGND $129.90
- Technical
- Relative Strength Index (RSI)
- FRME 41.12
- LGND 62.44
- Support Level
- FRME $35.11
- LGND $111.88
- Resistance Level
- FRME $38.19
- LGND $116.16
- Average True Range (ATR)
- FRME 0.88
- LGND 3.58
- MACD
- FRME -0.19
- LGND 0.89
- Stochastic Oscillator
- FRME 23.10
- LGND 85.19
About FRME First Merchants Corporation
First Merchants Corp, through its subsidiaries, provides its customers with financial services delivered locally by bankers. It offers personal banking, business banking, real estate mortgage lending, cash management services, brokerage, wealth management, and insurance. The company reports in only one segment which is community banking.
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.